DERM as of Nov 4 · 04:04 ET
DERMNasdaqPharmaceutical Preparations
Journey Medical Corp · Brief
Next report
7 days
Nov 11 · after closeest.Q3 FY26
Expected move
No implied move.
0 of 4≥ implied
- avg implied
- ±63.4%
- avg realized
- ±17.8%
Feb 5 '25—▼−5.30%—
Mar 26 '25—▼−3.58%—
May 14 '25—▲+18.93%—
Aug 12 '25—▼−15.11%—
Q3 FY25±56.7%▼−15.31%×0.27
Q1 FY26±87.6%▼−30.01%×0.34
May 13 '26±25.1%▲+22.35%×0.89
Q2 FY26±84.3%▲+3.42%×0.04
quarterimplied−90%0+90%realized×
Q2 FY26±84.3%▲+3.42%×0.04
May '26±25.1%▲+22.35%×0.89
Q1 FY26±87.6%▼−30.01%×0.34
Q3 FY25±56.7%▼−15.31%×0.27
Aug '25—▼−15.11%—
May '25—▲+18.93%—
2 older reports
Mar '25—▼−3.58%—
Feb '25—▼−5.30%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 11 report · est.Bull2 of 3
Bear2
AI captions · Sep 16 '26once per report · top 2 per case
Linked exposure
DERM report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.